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Abstract: The purpose of this work was to review the studies published over the last 10 years 
concerning the prevalence of retinopathy of prematurity (ROP) in Latin American countries, to 
determine if there was an improvement in ROP prevalence rates in that period, and to identify 
the inclusion criteria for patients at risk of developing ROP in the screening programs. A total 
of 33 studies from ten countries published between 2000 and 2010 were reviewed. Prevalence 
of any ROP stage in the regions considered ranged from 6.6% to 82%; ROP severe enough to 
require treatment ranged from 1.2% to 23.8%. There was no routine screening for ROP, and 
there was a lack of services for treatment of the disease in many countries. Inclusion criteria 
for patients in the studies ranged between birth weight #1500 g and #2000 g and gestational 
age #32 and ,37 weeks. Use of different inclusion criteria regarding birth weight and  gestational 
age in several Latin American studies hindered comparative analysis of the published data. 
Highly restrictive selection criteria for ROP screening in relation to birth weight and gestational 
age should not be used throughout most Latin American countries because of their different 
social characteristics and variable neonatal care procedures. The studies included in this review 
failed to provide adequate information to determine if the prevalence of ROP has decreased in 
Latin America.
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Introduction
Retinopathy of prematurity (ROP) is an important cause of avoidable childhood 
blindness in high human development index countries and also in several countries 
with emerging economies. According to Gilbert et al, it is estimated that over 50,000 
children in the world have ROP-related blindness and half of these children live in 
Latin America, which is an alarming finding.1,2
Several Latin American countries have reported increased survival rates of preterm 
infants due to improved quality of perinatal care. Consequently, more affected children 
has been observed, as well as an increased incidence of ROP-induced blindness. Many 
neonatal intensive care units have been established in this region in recent years, but 
without implementation of effective detection and treatment programs for ROP.3,4
In several Latin American countries, insufficient data on the prevalence of 
ROP hinder the establishment of strategies to minimize occurrence of the disease.1 
A reduction in ROP-induced childhood blindness relies on implementation of 
preventive measures, such as monitoring of oxygen delivery and early detection and 
treatment of affected patients.4
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To date, there are no studies analyzing ROP prevalence 
data between the different Latin American countries. 
Increased knowledge on the current scenario of ROP in this 
region may be a valuable tool in the prevention of childhood 
blindness. This review of published data on the prevalence 
of ROP in Latin America aims to analyze the inclusion 
criteria for patients at risk of developing ROP in the studies 
and to determine if there has been an improvement in ROP 
prevalence rates in the period under review.
Materials and methods
This is a database review of published prevalence data 
for ROP in Latin America from 2000 to 2010. The region 
under study comprised 16 Spanish-speaking or Portuguese-
speaking countries located in North, South, and Central 
America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa 
Rica, Ecuador, Guatemala, Honduras, Mexico, Nicaragua, 
Panama, Paraguay, Peru, Uruguay, and Venezuela, in addition 
to Cuba and the Dominican Republic in the Caribbean region). 
Our review focused on articles that described the prevalence 
of any stage ROP (defined according to the International 
Classification of ROP)5,6 and of ROP severe enough to require 
treatment (defined according to local treatment guidelines). 
Articles focusing on the prevalence of ROP are presented 
in table form in order to summarize the data. Other articles 
identified from the region and published within the same 
period but focusing on aspects of ROP other than prevalence 
were used only for discussion purposes in order to analyze 
data on guidelines and neonatal care procedures that could 
affect the prevalence of ROP in these countries.
Search terms used were “retinopathy of prematurity”, 
“retinopatía del prematuro”, “retinopatia da prematuri-
dade”, “prevalence”, “incidence”, “prevalencia”, “inciden-
cia”, “prevalência”, and “incidência”. Databases searched 
were PubMed (http://www.ncbi.nlm.nih.gov/sites/entrez), 
Lilacs (http://lilacs.bvsalud.org), Scielo (http://www.scielo.
org/php/index.php), and DOAJ (http://www.doaj.org).
Results
This literature review yielded 33 articles related to ROP 
prevalence, including 18 prospective studies, 13 retrospective 
studies, and two articles that did not specify the study design. 
Twenty-nine papers were institution-based studies and four 
were multicenter studies, two from Argentina,7,8 and one each 
from Chile9 and Cuba.10
All but one of the reviewed studies showed a cross-sectional 
analysis of prevalence. One article from Colombia described 
regional prevalence of ROP in a longitudinal manner.11 
Screening criteria for inclusion of patients in the different 
studies ranged between birth weight #1500 g and #2000 g 
and gestational age #32 and ,37 weeks. Prevalence of any 
stage ROP ranged from 6.6% to 82% and of severe ROP 
ranged from 1.2% to 23.8%. Papers that included national 
guidelines for ROP screening were from Argentina12,13 and 
Brazil.14
Papers with screening inclusion criteria for patients 
that mentioned birth weight #1500 g and/or gestational 
age #32 weeks originated from Argentina,8 Brazil,4,15–20 
Chile,9,21 and Colombia.11,22 In this group of papers, the 
prevalence of any stage ROP ranged from 24.2% in Brazil18 
to 62% in Colombia.22 The prevalence of severe ROP 
requiring treatment ranged from 5.3%15,18 to 9.3%19 in 
Brazil. Table 1 describes ROP prevalence rates and the 
main characteristics of the 33 studies included in this 
review. Most of the  published data from Latin America was 
identified in a non-PubMed database, ie, Scielo, which is 
an important tool for recovering published articles from 
this region.
Discussion
Only papers on prevalence of ROP are included in Table 1. 
Papers concerning aspects of ROP other than prevalence 
were included to collect data on guidelines and neonatal care 
procedures that could affect the prevalence of ROP in these 
countries, but are not included in Table 1. Use of different 
inclusion criteria for patients in the screening programs 
performed in several Latin American countries, as well as 
in the reviewed studies, limited any comparative analysis 
of the published data. Most studies provided insufficient 
data to enable detailed analysis of the prevalence of ROP 
in the region. The studies also failed to provide adequate 
information to determine if the prevalence of ROP is 
decreasing in Latin America.
Argentina
The scenario of ROP is quite complex in Argentina. Until 
recently, Argentina had the highest rate of ROP-induced 
blindness of all the Latin American countries, with an ROP 
prevalence of about 60%, a rate three times higher than that 
usually reported in industrialized countries in the early 1990s, 
according to data from Gilbert et al.1,2
Guidelines and recommendations for ROP screening were 
published in Argentina in 199912 and revised in 2008.13 These 
guidelines recommend that an ROP examination should be 
performed in all infants with a birth weight #1500 g and/or 
gestational age #32 weeks, and in older babies (gestational 
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age ,37 weeks) with an unstable clinical course or with 
risk factors.
In 2003, a multicenter collaborative working group was 
created to address the prevention of ROP-induced childhood 
blindness in Argentina. This group, affiliated with the Ministry 
of Health and Environment in Argentina, published the results 
of a nationwide survey involving 100 neonatal centers in 
2006. The survey was designed to increase knowledge 
about the characteristics of these units with regard to ROP 
screening programs. Only 47 centers participated in the 
survey effectively (36 provided all the information requested, 
but five of these centers did not perform ROP screening). 
Eleven centers provided general information, but failed to 
provide data on screening and prevalence of ROP. The study 
included a total of 4561 patients from all institutions that 
performed ROP screening. Infants were divided according 
to birth weight, as follows: birth weight ,1000 g (n = 336); 
birth weight 1000–1500 g (n = 1353); and birth weight 
1501–2000 g (n = 2872). Among the patients with birth 
weight ,1000 g, 19% (64/336) required treatment for severe 
ROP compared with 6.9% (93/1353) in the group with birth 
weight 1000–1500 g and 1.6% (47/2872) in the group with 
birth weight 1501–2000 g. In addition, five patients with 
birth weight .2000 g required treatment, and 13 infants 
missed the opportunity for treatment. The study reported 
that 57% of neonatal unit care centers were still unaware of 
the incidence of ROP and more than 70% of these centers 
felt that this issue was out of control or improving slowly. 
Moreover, the study reported deficiencies in efforts to 
prevent ROP as a result of an insufficient number of nurses, 
Table 1 Studies on the prevalence of retinopathy of prematurity in Latin America
Country 
(Reference)
Year of  
publication
Study  
design
Patients  
(n)
Inclusion criteria,  
(BW, GA)
% any stage  
ROP
% ROP requiring 
treatment
Argentina47 2004 R 584 ,2000 g; ,36 weeks 26.4% N/R
Argentina7 2006 multicenter R 4,561 ,2000 g N/R 19% ,1000 g
Argentina8 2010 multicenter R 956 #1500 g; #32 weeks 26.2% 7%
Bolivia34 2002 R 84 N/R 14.3% N/R
Brazil25 2001 N/R 50 ,1750 g; ,36 weeks 28% N/R
Brazil17 2006 P 114 ,1500 g; ,32 weeks 27.2% 5.3%
Brazil26 2007 P 286 #37 weeks 20% 2%
Brazil4 2007 P 300 ,1500 g; ,32 weeks 24.7% 6%
Brazil16 2007 P 329 ,1500 g; ,32 weeks 25.5% 5.5%
Brazil30 2010 P 70 #1500 g 35.7% 10%
Brazil20 2010 R 73 #1500 g; #32 weeks 53.4% N/R
Brazil27 2009 R 147 N/R 23% 3%
Brazil28 2009 R 663 #1500 g; #36 weeks 62.4% N/R
Brazil18 2009 P 450 #1500 g; #32 weeks 24.2% 5.3%
Brazil17 2009 P 407 ,1500 g; ,32 weeks 25.5% 5.8%
Brazil19 2010 P 152 #1500 g; #32 weeks 27.8% 9.3%
Chile21 2000 P 248 ,1500 g; ,32 weeks 28.2% N/R
Chile32 2003 R 253 ,1500 g; ,34 weeks 33.6% 1.2%
Chile33 2004 P 205 ,1500 g 71.2% 12.3%
Colombia11 2006 R 1174 ,1500 g; ,32 weeks N/R 8%
Colombia22 2007 R 234 ,1500 g; ,32 weeks 62% N/R
Cuba36 2006 N/R 227 ,1700 g; ,32 weeks 6.6% 9.5%
Cuba37 2007 P 66 ,1750 g; ,35 weeks 24.2% 4.5%
Cuba10 2008 multicenter R 4,396 ,1700 g; ,35 weeks 11.2% 2%
Cuba38 2010 P 31 ,1500 g 25.8% 12.9%
Cuba39 2010 P 137 ,1750 g; ,35 weeks 15.3% 5.1%
Guatemala40 2010 P 88 ,2000 g; ,35 weeks 49% 13%
Mexico42 2005 P 57 ,1500 g 28% 10.5%
Mexico43 2007 P 2,014 ,1500 g 22.3% 11.4%
Mexico44 2008 P 29 ,1500 g; ,34 weeks 24.1% 10.3%
Mexico48 2006 P 170 ,1500 g; ,35 weeks 10% 2.7%
Nicaragua45 2004 R 77 ,36 weeks 82% 23.8%
Peru46 2007 R 136 ,1500 g 70.6% 19.1%
Abbreviations: Bw, birth weight; GA, gestational age; N/R, not reported; ROP, retinopathy of prematurity.
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oximeters, and pulse oximeters, and inadequate monitoring 
of oxygen saturation. Diagnosis of ROP was hampered by 
a lack of trained ophthalmologists to diagnose and treat 
the disease outside the city of Buenos Aires, the capital of 
Argentina. Lack of adequate ophthalmological examination 
using indirect binocular ophthalmoscopy in screening 
was also reported. Mortality among patients with a birth 
weight ,1500 g was high, reflecting inadequate neonatal 
care procedures. Several ROP cases were detected as a missed 
opportunity for treatment. The authors stated that the data 
presented provided an unrealistic representation of ROP in 
Argentina, because many centers had no ROP screening 
programs and, therefore, the disease was still likely to be 
under-reported in this country.7
A study published in 2007 investigated 809 patients admit-
ted to a pediatric hospital in Buenos Aires between 1996 and 
2003 for treatment of ROP. The sample also included infants 
with a birth weight .1500 g and gestational age .35 weeks. 
Of these patients, 55% (443/809) had a threshold ROP or 
greater (stage 4 or 5 ROP and aggressive posterior ROP), 
and 25.7% were considered atypical (or unusual) cases, ie, 
had severe ROP associated with birth weight .1500 g and 
gestational age .31 weeks. These atypical findings were 
probably due to unequal levels of assistance according to the 
source of referral of patients for treatment of ROP in Buenos 
Aires. Of 809 patients referred for treatment, 89% (n = 718) 
received treatment, 59 patients missed the opportunity for 
treatment due to late referral, and 32 patients did not require 
treatment. This study showed an alarming increase in the 
number of patients with severe ROP among infants with 
higher birth weight and older gestational age.23
An excellent publication on technical guidelines for the 
management of ROP in Argentina was published by the 
Secretary of Health of the Federal Government in 2008 and 
is available on the Internet.24
Brazil
Guidelines for ROP screening and treatment were published 
in Brazil in 2007, and recommended that ROP examination 
be performed in all infants with a birth weight #1500 g 
and/or gestational age #32 weeks.14 The selection criteria 
for screening in Brazil are similar to those recommended 
in Argentina.12,13
Currently, there are no population-based studies in Brazil 
that enable analysis of ROP epidemiology as a whole in such 
an ethnically and socially diverse population. On the other 
hand, 12 institution-based studies were identified, enabling 
a reasonable understanding of the behavior of the disease 
in Brazil.
In 2001, the prevalence of any stage ROP was determined 
to be 28% among 50 preterm infants of gestational 
age ,36 weeks and birth weight ,1750 g in the northeastern 
region of Brazil. This study, with a small number of patients 
and including babies with a birth weight .1500 g and/or 
older than 32 weeks’ gestational age, was published before 
the Brazilian guidelines were established and did not report 
data on the prevalence of severe ROP.25
In a prospective study conducted in the city of Joinville, 
southern Brazil, Bonotto et al investigated 286 preterm 
infants of gestational age #37 weeks at birth and reported 
a 20% prevalence of ROP of any stage. However, their 
inclusion of patients with a gestational age #37 weeks 
may have underestimated the prevalence of ROP, especially 
among those requiring treatment, since the authors reported 
that all infants who required treatment had a birth weight 
,1399 g and a gestational age ,33 weeks.26
In 2009, Lorena and Brito studied 147 patients in the 
state of São Paulo, southeastern Brazil, and reported that 
23% of these patients had any stage ROP and 3% (only one 
patient) required treatment. Of 35 patients with ROP, 97% 
(n = 34) developed ROP stage 1 with spontaneous regression. 
This study failed to describe the inclusion criteria or mean 
and standard deviation for birth weight and gestational 
age, which limited any comparative data analysis. Risk 
factors for ROP were assessed, but no logistic regression 
was performed to determine their influence in relation to 
birth weight and gestational age, which are important risk 
factors for ROP.27
In 2009, Schumann et al reported a 53.4% incidence 
of ROP in 73 patients with a birth weight #1500 g and/or 
gestational age #32 weeks in the state of Rio de Janeiro, 
southeastern Brazil. Although this study did not report data 
on the prevalence of severe ROP, the patient inclusion criteria 
were in accordance with the Brazilian guidelines.20
In a study conducted in the city of Natal, northeastern 
Brazil, Pinheiro et al retrospectively analyzed data from 
663 preterm infants with a birth weight #1500 g and/or 
gestational age #36 weeks, and reported a 62.4% prevalence 
of ROP between 2004 and 2006. The study included 
appropriate considerations regarding risk factors for ROP 
using logistic regression.28
In five prospective studies from Porto Alegre, southern 
Brazil, Fortes Filho et al investigated ROP prevalence rates 
after 2002. Among babies with a birth weight #1500 g and/or 
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gestational age # 32 weeks, the prevalence of any stage ROP 
was reported to be about 25%, whereas prevalence of severe 
ROP was reported to be about 5%.4,15–18 The occurrence 
of ROP was significantly higher in babies with a birth 
weight ,1000 g and/or gestational age ,28 weeks, reaching 
about 45% and 17%, respectively, for any stage ROP and 
severe ROP.29 All of these studies were in accordance with the 
Brazilian guidelines, included a higher number of patients, 
and clearly described their methods and results in order to 
allow comparisons with international studies on the same 
topic.
In 2010, Shinsato et al prospectively reported a 35.7% 
incidence of ROP among 70 patients with birth weight 
#1500 g in the state of São Paulo, southeastern  Brazil. 
This study had a small sample size and failed to establish 
a cutoff point for gestational age or the mean and standard 
deviation (or median and interquartile range) for birth weight 
and gestational age in the cohort of patients, thereby hinder-
ing a comparative analysis of results.30
Significant variations in prevalence of ROP observed 
in several Brazilian studies reflect the heterogeneity of the 
population across regions as well as the different screening 
criteria used, and reflect a marked variation in neonatal 
care procedures currently performed in the country. Zin 
et al recently recommended that ROP programs in Brazil 
use a wider criterion of birth weight #1500 g or gesta-
tional age #35 weeks until further evidence-based crite-
ria become available, although this would mean a slight 
increase in workload for the ophthalmologists performing 
ROP screening. These authors also suggested that survival 
rates for very low birth weight preterm infants in neonatal 
intensive care units reflect the quality of local neonatal care. 
Local neonatal intensive care unit screening criteria could 
be better adjusted, according to data on survival rates for 
babies with a birth weight ,1500 g.31
Chile
Chile is one of the countries in Latin America with a high 
level of neonatal health care. In 1998, a national  commission 
for follow-up of preterm infants was established, consisting 
of neonatologists who, working jointly with the Ministry of 
Health of Chile, undertook progressive follow-up of patients 
of low birth weight and gestational age, obtaining data from 
birth to the age of 7 years. In 2005, national guidelines 
and protocols were published in Chile, with the aim of 
standardizing neonatal care in that country, thus enabling 
better comparative analysis of the results obtained.9
In 2000, Bancalari et al analyzed 248 very low birth 
weight preterm infants and reported a 28.2% rate for any 
stage ROP, although the number of infants treated for severe 
ROP was not described. The sample included infants with 
birth weight ,1500 g, and 13% of these patients had any 
stage ROP. Nine infants with birth weight ,1000 g and 
15 infants with birth weight 1000–1500 g developed severe 
ROP (stage 3, 4, or 5). This situation is different from that 
usually observed, whereby a higher incidence of ROP is 
expected in infants of lower birth weight. However, this study 
did not reported enough data to allow comparison.21
In 2003, another study investigated 253 patients with 
birth weight ,1500 g and/or gestational age ,34 weeks. 
ROP of any stage was identified in 33.6% of patients. 
Total blindness arising from ROP was detected in three 
patients (1.2%).32 In 2004, Salas et al reported 12.3% of 
severe ROP cases as needing treatment, as well as a rate 
of 71.2% for any stage ROP in 205 preterm infants with 
birth weight ,1500 g.33 In 2006, another Chilean study 
reported clinical follow-up of preterm infants with birth 
weight ,1000 g, and included infants with ROP in the 
analysis. The mortality rate among extremely low birth 
weight preterm infants was 55.2%. Among the surviving 
infants, 80% (n = 76) had ROP of any stage and 11.5% 
(n = 11) required laser treatment; the study reported no cases 
of ROP-induced blindness. This study was not specifically 
designed to investigate ROP and so is not included in 
Table 1. However, indicators of prenatal antecedents, seque-
lae, complications, and mortality rates among extremely 
low birth weight preterm infants were reported in the study, 
indicating excellent perinatal care in Chile.34  Current analy-
sis of ROP in Chile is available on the Internet at http://www.
retinopatiadelprematuro.cl/ and at http://www.prematuros.
cl/webfebrero06/rop/rop_chile.htm.
Colombia
According to a study published by Zuluaga et al, until 2006 
there were no government directives in Colombia indicating 
that routine screening of infants should be performed for 
detection and treatment of ROP. This longitudinal study 
from 2001 to 2005 investigated 1174 patients with a birth 
weight ,1500 g and/or gestational age ,32 weeks, and 
reported that the proportion of newborns screened increased 
from 29.3% to 98.9% and that children requiring treatment 
decreased from 18% to 4.9% during the same period.11 
Studies of ROP are still scarce in Colombia, but most 
regions are awakening to the importance of investigating 
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for the disease. Protocols are in place and professionals are 
being trained to diagnose patients at risk of developing ROP 
accurately and early, given that ROP was one of the main 
causes of blindness in the city of Cali in 2005.35
Cuba
A program to address ROP was launched in 1997 for Latin 
American countries, and Cuba decided to adopt this program. 
In 2003, all Cuban neonatal centers joined the program and 
the first results were published in 2006. These results were 
from an institution-based study analyzing 227 infants with 
birth weight ,1700 g and gestational age ,32 weeks, and 
reported that 6.6% of patients had ROP of any stage and 9.5% 
developed ROP stage 3. Most infants with ROP had a birth 
weight ,1500 g. This study failed to describe the number 
of patients effectively treated and whether there were cases 
of blindness due to progression of ROP, although an ROP 
3 incidence of 9.5% was reported.36 Inclusion of patients 
weighing up to 1700 g at birth may be an interesting piece 
of information for Cuba, but hinders further consideration 
of the prevalence of the disease in that country.
An institution-based study conducted between 2003 
and 2005 and published in 2007 analyzed data from 
66 preterm infants with birth weight ,1750 g and 
gestational age ,35 weeks. Any stage ROP was diagnosed 
in 24.4% of patients, and 4.5% developed ROP 3 requiring 
treatment.37 However, this study used inclusion criteria 
that were quite different from those used in the previous 
investigation, despite being published only one year later, 
so a comparison of the two studies was not appropriate, 
nor with any other Latin American studies or studies from 
industrialized countries, due to the small sample and broad 
inclusion criteria.
A Cuban multicenter study from 2008 included data 
on 4396 preterm infants with birth weight ,1700 g and 
gestational age ,35 weeks from 33 neonatal intensive 
care units around the country, and reported a 11.2% rate of 
any stage ROP and a 2% rate of severe ROP needing treat-
ment.10 Cuba, according to published data, appears to have a 
good survival rate and low incidence of severe ROP among 
very low birth weight preterm infants for Latin American 
countries, but rates of 2%–12.9% for treatable ROP are still 
high rate compared with rates in industrialized countries. 
However, multicenter or population-based studies with much 
larger numbers of patients are needed for comparison with 
studies from other Latin American countries. Data from two 
other studies from Cuba are shown in Table 1. Both studies 
included a small number of patients and different criteria for 
selection of patients,38,39 so a comparison between them is not 
possible, nor with other Latin American studies or studies in 
industrialized countries.
Guatemala
A Guatemalan study of 88 infants with birth weight ,2000 g 
and gestational age ,35 weeks published in 2010 showed a 
ROP prevalence of 43%. Of these patients, 13% developed 
ROP 3 and were referred for treatment. Three patients (3%) 
undergoing treatment progressed to ROP 5. This study was 
the first to analyze ROP in Guatemala and demonstrated a 
high prevalence of severe ROP (stage 3, 4, or 5), despite 
including infants weighing up to 2000 g at birth. The 
authors suggested that a formal ROP screening program 
be introduced in all neonatal centers, since no screening 
examination is currently performed for detection of ROP 
in that country and only a few infants are examined by 
 ophthalmologists after hospital discharge when recom-
mended by a neonatologist.40
Mexico
Local studies on the prevalence of ROP in Mexico are 
scarce41 despite the existence of a well structured national 
protocol for ROP screening. Guidelines for the manage-
ment of ROP were published by the Secretary of Health 
of the Federal Government in 2008, and are available on 
the Internet at http://www.generoysaludreproductiva.gob.
mx/IMG/pdf/WEB-Lineamiento_Rinopatia_2007.pdf and 
also on the Program for the Prevention of Blindness due 
to Retinopathy of Prematurity at Hospital de Clínicas de 
Porto Alegre (PROROP) website: http://prorop.com/files/
arq_ptg_6_1_254.pdf.
A study published in 2005 analyzed 57 preterm infants 
with a birth weight ,1500 g and showed a 28% prevalence 
of any stage ROP and 10.5% of severe ROP. Two patients 
became blind despite treatment.42 Another study published 
in 2007 included data on 2014 preterm infants with birth 
weight ,1500 g. The reported occurrence of severe ROP 
was 11.4%.43 Both studies reported that patients were included 
in the screening protocol according to the criteria defined 
by the American Academy of Pediatrics and the American 
Academy of Ophthalmology, which are criteria intended 
for industrialized countries with excellence in perinatal care, 
and this is not available in most Latin American countries. 
This situation needs to be revised in Latin America due to 
the risk that patients not included in screening programs 
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because of restrictive selection criteria may develop ROP 
severe enough to require treatment, as often mentioned in 
the published literature.4,31
Another Mexican study, published in 2008, analyzed 
data from 29 patients with birth weight 900–1500 g and 
gestational age ,34 weeks, and reported that 24.1% of 
patients developed ROP and 10.3% required treatment. One 
infant became blind despite treatment.44 This study had a 
small sample size, so further comparison was not possible, but 
inclusion of patients up to 34 weeks’ gestational age appears 
to be appropriate for the Mexican scenario.
Nicaragua
The only study on ROP in Nicaragua, published in 2004, 
reported data for 77 preterm infants. Of these, 81.8% had 
any stage ROP and 54.8% developed higher-stage, thresh-
old disease, or stage 4A, 4B, or 5 disease. Only 23.8% of 
cases were treated with cryotherapy or laser. The study was 
institution-based, had a small sample size, failed to describe 
patient inclusion criteria regarding birth weight, and showed 
a very high incidence of severe ROP. Moreover, the authors 
reported that only half of the patients were treated, demon-
strating that strategies for the prevention of ROP-induced 
blindness are still in the early stages of development in this 
country.45
Peru
Peru still lacks strategies for adequate diagnosis and treat-
ment of ROP, thus increasing the likelihood of a poor prog-
nosis when the disease occurs. Peru also lacks professional 
expertise and technology for treatment. A study on the 
prevalence of ROP involving 136 infants with birth weight 
500–1500 g was published in Peru in 2007 and reported an 
incidence of 70.5% of any stage ROP. Of these patients, 
19.1% required laser treatment and 2.2% of patients pro-
gressed to bilateral blindness despite treatment. Infants were 
examined before 4 weeks of life and weekly thereafter. The 
main problems identified were a lack of qualified ophthal-
mologists to care for preterm infants and unavailability of 
laser equipment, so that children often needed to be referred 
to centers with adequate resources for treatment. This situ-
ation limits access to timely treatment and also increases 
morbidity rates. Patients of gestational age ,31 weeks were 
2.7 times more likely to develop ROP and infants with birth 
weight ,1190 grams were four times more likely to develop 
any stage ROP. The study is regarded as the first to analyze 
ROP statistics in Peru.46
Summary
Additional multicenter and population-based studies are 
needed in Latin America to analyze further the high preva-
lence of ROP observed in these countries. It is necessary to 
improve the scientific quality of the information published 
in order to permit comparison with articles originating from 
more industrialized countries. Most of the international pub-
lished data on prevalence of ROP includes cohorts of patients 
with birth weight #1500 g and/or gestational age #32 weeks, 
and it is suggested that future articles from Latin America 
use the same inclusion criteria to enable better comparison 
of data, despite broader inclusion criteria being used in the 
regional screening programs. Highly restrictive selection 
criteria in relation to birth weight and gestational age for 
detection of ROP, like those used in industrialized countries 
such as the USA, UK, and Canada, should not be used in 
Latin American countries because of the different social 
characteristics and neonatal care procedures involved. This 
was observed in studies from Mexico,42,43 and the concept is 
reinforced by Zin et al31 and by Fortes Filho et al.4
Some studies reviewed here reveal that there are few 
qualified ophthalmologists to care for preterm infants. On 
the other hand, papers from Chile, Brazil, Argentina, Cuba, 
and Mexico showed an improvement in the management of 
ROP, as well as those from Colombia and Peru. Nicaragua, 
Bolivia, and Guatemala are embarking on better management 
of ROP. It is thus of paramount importance that ophthalmolo-
gists, neonatologists, and nursing staff become fully aware of 
their role in neonatal intensive care units and that measures 
to prevent ROP be implemented with the support of health 
care managers, particularly in countries where public health 
is a commitment and duty of the State.
Conclusion
According to the studies reviewed here, the prevalence of 
any stage ROP ranges from 6.6% to 82% and of severe ROP 
ranges from 1.2% to 25% in Latin American countries. Most 
studies have been cross-sectional and provide insufficient 
data to allow a detailed analysis of the prevalence of ROP 
in the regions. The studies analyzed also fail to provide 
adequate longitudinal information to determine whether or 
not the regional prevalence of ROP is decreasing. The use 
of different patient inclusion criteria in the studies limits a 
comparative analysis of the published data. Some studies 
have reported improvement in survival rates among preterm 
infants and improved quality of perinatal care. Difficulties 
reported include insufficient personnel and equipment, but 
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government support and technical published guidelines are 
provided for several countries.
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